The Latin America, Middle East and Africa Bovine Lactoferrin Market would witness market growth of 11.0% CAGR during the forecast period (2023-2030). In the year 2026, the LAMEA market's volume is expected to surge to 36.8 Tonnes, showcasing a growth of 12.7% (2023-2030).
Human, bovine, camel, and goat milk include lactoferrin, an iron-binding protein. This component aids in the treatment of diarrhoea, hepatitis C, and stomach and intestinal ulcers. It is also an antioxidant to combat viral and bacterial infections. One of the primary drivers behind adopting bovine lactoferrin is the heightened awareness among consumers regarding its health-promoting properties. As information about bovine lactoferrin's immune-modulating, antimicrobial, and nutritional attributes become more widespread, consumers are actively seeking products that contain this bioactive compound.
Consumers are increasingly prioritizing preventive healthcare measures, and the immune-supporting capabilities of bovine lactoferrin align seamlessly with this trend. The market has responded with many products, including supplements, functional foods, and infant formulas, catering to health-conscious individuals.
The integration of lactoferrin into everyday food items makes it more accessible to consumers in Saudi Arabia who are seeking convenient ways to enhance their diet with health-promoting ingredients. The versatility of bovine lactoferrin allows for diverse product formulations, including supplements, powders, capsules, and functional foods in Saudi Arabia. Thus, due to these aspects, the bovine lactoferrin market will expand across the LAMEA region in upcoming years.
The Brazil market dominated the LAMEA Bovine Lactoferrin Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $15,400 Thousands by 2030. The Argentina market is showcasing a CAGR of 11.6% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 10.6% during (2023 - 2030).
Based on Application, the market is segmented into Infant Formula, Dietary Supplements, Pharmaceutical, and Others. Based on Product Type, the market is segmented into Freeze-dried and Spray-dried. Based on Function, the market is segmented into Iron Absorption, Antibacterial, Immune Cell Stimulation and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Human, bovine, camel, and goat milk include lactoferrin, an iron-binding protein. This component aids in the treatment of diarrhoea, hepatitis C, and stomach and intestinal ulcers. It is also an antioxidant to combat viral and bacterial infections. One of the primary drivers behind adopting bovine lactoferrin is the heightened awareness among consumers regarding its health-promoting properties. As information about bovine lactoferrin's immune-modulating, antimicrobial, and nutritional attributes become more widespread, consumers are actively seeking products that contain this bioactive compound.
Consumers are increasingly prioritizing preventive healthcare measures, and the immune-supporting capabilities of bovine lactoferrin align seamlessly with this trend. The market has responded with many products, including supplements, functional foods, and infant formulas, catering to health-conscious individuals.
The integration of lactoferrin into everyday food items makes it more accessible to consumers in Saudi Arabia who are seeking convenient ways to enhance their diet with health-promoting ingredients. The versatility of bovine lactoferrin allows for diverse product formulations, including supplements, powders, capsules, and functional foods in Saudi Arabia. Thus, due to these aspects, the bovine lactoferrin market will expand across the LAMEA region in upcoming years.
The Brazil market dominated the LAMEA Bovine Lactoferrin Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $15,400 Thousands by 2030. The Argentina market is showcasing a CAGR of 11.6% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 10.6% during (2023 - 2030).
Based on Application, the market is segmented into Infant Formula, Dietary Supplements, Pharmaceutical, and Others. Based on Product Type, the market is segmented into Freeze-dried and Spray-dried. Based on Function, the market is segmented into Iron Absorption, Antibacterial, Immune Cell Stimulation and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
List of Key Companies Profiled
- Royal FrieslandCampina N.V.
- Fonterra Co-operative Group Limited
- Saputo, Inc.
- Glanbia PLC
- Noumi Limited
- Synlait Milk Limited
- MILEI GmbH (Morinaga Milk Industry Co., Ltd.)
- Bega Cheese Limited
- Beston Global Food Company Limited
- Savencia SA
Market Report Segmentation
By Application (Volume, Tonnes, USD Million, 2019-2030)- Infant Formula
- Dietary Supplements
- Pharmaceutical
- Others
- Freeze-dried
- Spray-dried.
- Iron Absorption
- Antibacterial
- Immune Cell Stimulation
- Others
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 5. LAMEA Bovine Lactoferrin Market by Application
Chapter 6. LAMEA Bovine Lactoferrin Market by Product Type
Chapter 7. LAMEA Bovine Lactoferrin Market by Function
Chapter 8. LAMEA Bovine Lactoferrin Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- Royal FrieslandCampina N.V.
- Fonterra Co-operative Group Limited
- Saputo, Inc.
- Glanbia PLC
- Noumi Limited
- Synlait Milk Limited
- MILEI GmbH (Morinaga Milk Industry Co., Ltd.)
- Bega Cheese Limited
- Beston Global Food Company Limited
- Savencia SA
Methodology
LOADING...
